BiotechTube

Human Fibrinogen Concentrate

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fibrinogen Deficiency

Conditions

Fibrinogen Deficiency

Trial Timeline

Jul 1, 2007 → May 1, 2008

NCT ID
NCT00496262

About Human Fibrinogen Concentrate

Human Fibrinogen Concentrate is a phase 2 stage product being developed by CSL for Fibrinogen Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT00496262. Target conditions include Fibrinogen Deficiency.

What happened to similar drugs?

1 of 5 similar drugs in Fibrinogen Deficiency were approved

Approved (1) Terminated (2) Active (2)
✅Traditional Cryoprecipitate + Pathogen-Reduced CryoprecipitateCerusApproved
❌Fibrinogen Concentrate, Human (FCH) + CryoprecipitateCSLPhase 3
🔄CSL511 Fibrinogen concentrate (human) + CryoprecipitateCSLPhase 3
🔄BT524 (Part I) + BT524 (Part II)ICON plc.Phase 3
❌FIB GrifolsGrifolsPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01283321Phase 2Terminated
NCT00496262Phase 2Completed

Competing Products

9 competing products in Fibrinogen Deficiency

See all competitors
ProductCompanyStageHype Score
Fibrinogen Concentrate, Human (FCH) + CryoprecipitateCSLPhase 3
32
Haemocomplettan® P + Human albumin (Placebo)CSLPhase 2/3
38
FCHCSLPre-clinical
26
CSL511 Fibrinogen concentrate (human) + CryoprecipitateCSLPhase 3
47
BT524 (Part I) + BT524 (Part II)ICON plc.Phase 3
37
FIB GrifolsGrifolsPhase 3
29
Human Plasma-Derived Fibrinogen ConcentrateGrifolsPhase 1/2
29
Pathogen Reduced Cryoprecipitated Fibrinogen Complex + Cryoprecipitated-Antihemophilic FactorCerusPre-clinical
23
Traditional Cryoprecipitate + Pathogen-Reduced CryoprecipitateCerusApproved
33